A cheap and widely-available antibiotic pill halves the risk of people exposed to drug-resistant tuberculosis from contracting that particularly deadly strain of the disease, researchers announced on Nov 17 (2023).
Tuberculosis is the second deadliest infectious disease, according to the World Health Organization (WHO), killing only slightly fewer people than Covid-19 last year (2022).
